Annual Cash & Cash Equivalents
$48.88 M
-$45.30 M-48.10%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual cash & cash equivalents is $48.88 million, with the most recent change of -$45.30 million (-48.10%) on December 31, 2023.
- During the last 3 years, AUPH annual cash & cash equivalents has fallen by -$223.47 million (-82.05%).
- AUPH annual cash & cash equivalents is now -84.03% below its all-time high of $306.02 million, reached on December 31, 2019.
Performance
AUPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$37.14 M
+$3.73 M+11.18%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly cash and cash equivalents is $37.14 million, with the most recent change of +$3.73 million (+11.18%) on September 30, 2024.
- Over the past year, AUPH quarterly cash and cash equivalents has increased by +$3.73 million (+11.18%).
- AUPH quarterly cash and cash equivalents is now -87.86% below its all-time high of $306.02 million, reached on December 31, 2019.
Performance
AUPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AUPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.1% | +11.2% |
| 3 y3 years | -82.0% | -56.8% |
| 5 y5 years | -58.6% | -56.8% |
AUPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.9% | at low | -84.0% | +11.2% |
| 5 y | 5-year | -84.0% | at low | -87.9% | +11.2% |
| alltime | all time | -84.0% | >+9999.0% | -87.9% | -100.0% |
Aurinia Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.14 M(+11.2%) |
| Jun 2024 | - | $33.41 M(-48.2%) |
| Mar 2024 | - | $64.46 M(+31.9%) |
| Dec 2023 | $48.88 M(-48.1%) | $48.88 M(+5.3%) |
| Sep 2023 | - | $46.40 M(-43.2%) |
| Jun 2023 | - | $81.71 M(-8.2%) |
| Mar 2023 | - | $89.00 M(-5.5%) |
| Dec 2022 | $94.17 M(-59.4%) | $94.17 M(+9.4%) |
| Sep 2022 | - | $86.05 M(-43.2%) |
| Jun 2022 | - | $151.63 M(+14.4%) |
| Mar 2022 | - | $132.54 M(-42.8%) |
| Dec 2021 | $231.90 M(-14.9%) | $231.90 M(+302.7%) |
| Sep 2021 | - | $57.59 M(-52.6%) |
| Jun 2021 | - | $121.56 M(-22.4%) |
| Mar 2021 | - | $156.59 M(-42.5%) |
| Dec 2020 | $272.35 M(-11.0%) | $272.35 M(+9.5%) |
| Sep 2020 | - | $248.76 M(-5.9%) |
| Jun 2020 | - | $264.35 M(-3.6%) |
| Mar 2020 | - | $274.21 M(-10.4%) |
| Dec 2019 | $306.02 M(+159.4%) | $306.02 M(+127.5%) |
| Sep 2019 | - | $134.54 M(+2.3%) |
| Jun 2019 | - | $131.49 M(-6.3%) |
| Mar 2019 | - | $140.36 M(+19.0%) |
| Dec 2018 | $117.97 M(-28.8%) | $117.97 M(+2.7%) |
| Sep 2018 | - | $114.90 M(-13.2%) |
| Jun 2018 | - | $132.30 M(+0.8%) |
| Mar 2018 | - | $131.23 M(-20.8%) |
| Dec 2017 | $165.63 M(+317.7%) | $165.63 M(+89.2%) |
| Sep 2017 | - | $87.55 M(-51.3%) |
| Jun 2017 | - | $179.72 M(-9.7%) |
| Mar 2017 | - | $199.07 M(+402.1%) |
| Dec 2016 | $39.65 M(+588.8%) | $39.65 M(+221.5%) |
| Sep 2016 | - | $12.33 M(+35.2%) |
| Jun 2016 | - | $9.13 M(+161.3%) |
| Mar 2016 | - | $3.49 M(-39.3%) |
| Dec 2015 | $5.76 M(-74.6%) | $5.76 M(-45.7%) |
| Sep 2015 | - | $10.59 M(-32.6%) |
| Jun 2015 | - | $15.73 M(-17.4%) |
| Mar 2015 | - | $19.04 M(-16.1%) |
| Dec 2014 | $22.71 M(+1146.9%) | $22.71 M(-11.1%) |
| Sep 2014 | - | $25.53 M(-34.7%) |
| Jun 2014 | - | $39.09 M(-9.7%) |
| Mar 2014 | - | $43.29 M(+2277.2%) |
| Dec 2013 | $1.82 M(+884.3%) | $1.82 M(-59.5%) |
| Sep 2013 | - | $4.50 M(+890.9%) |
| Jun 2013 | - | $454.30 K(+1260.2%) |
| Mar 2013 | - | $33.40 K(-81.9%) |
| Dec 2012 | $185.00 K(-96.9%) | $185.00 K(-35.9%) |
| Sep 2012 | - | $288.50 K(-78.6%) |
| Jun 2012 | - | $1.35 M(-59.7%) |
| Mar 2012 | - | $3.35 M(-43.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $5.92 M(-6.7%) | $5.92 M(-19.2%) |
| Sep 2011 | - | $7.33 M(-15.2%) |
| Jun 2011 | - | $8.64 M(-15.0%) |
| Mar 2011 | - | $10.17 M(+60.3%) |
| Dec 2010 | $6.35 M(+38.5%) | $6.35 M(-9.3%) |
| Sep 2010 | - | $7.00 M(+75.9%) |
| Jun 2010 | - | $3.98 M(-21.5%) |
| Mar 2010 | - | $5.07 M(+10.6%) |
| Dec 2009 | $4.58 M(-78.3%) | $4.58 M(-21.6%) |
| Sep 2009 | - | $5.85 M(-7.4%) |
| Jun 2009 | - | $6.31 M(+36.7%) |
| Mar 2009 | - | $4.62 M(-78.1%) |
| Dec 2008 | $21.12 M(-34.7%) | $21.12 M(-20.3%) |
| Sep 2008 | - | $26.49 M(-11.1%) |
| Jun 2008 | - | $29.79 M(+43.1%) |
| Mar 2008 | - | $20.81 M(-35.7%) |
| Dec 2007 | $32.34 M(+142.0%) | $32.34 M(-9.8%) |
| Sep 2007 | - | $35.85 M(-11.2%) |
| Jun 2007 | - | $40.37 M(-2.8%) |
| Mar 2007 | - | $41.52 M(+210.7%) |
| Dec 2006 | $13.36 M(-20.0%) | $13.36 M(-14.7%) |
| Sep 2006 | - | $15.67 M(+4.0%) |
| Jun 2006 | - | $15.07 M(+2.6%) |
| Mar 2006 | - | $14.69 M(-12.1%) |
| Dec 2005 | $16.71 M(+12.3%) | $16.71 M(-13.6%) |
| Sep 2005 | - | $19.33 M(+109.5%) |
| Jun 2005 | - | $9.23 M(-24.8%) |
| Mar 2005 | - | $12.28 M(-17.5%) |
| Dec 2004 | $14.88 M(-46.1%) | $14.88 M(-30.6%) |
| Sep 2004 | - | $21.45 M(-14.6%) |
| Jun 2004 | - | $25.11 M(+18.1%) |
| Mar 2004 | - | $21.25 M(-23.1%) |
| Dec 2003 | $27.62 M(+39.2%) | $27.62 M(-34.7%) |
| Sep 2003 | - | $42.29 M(+27.3%) |
| Jun 2003 | - | $33.21 M(+91.5%) |
| Mar 2003 | - | $17.34 M(-12.6%) |
| Dec 2002 | $19.85 M(-35.6%) | $19.85 M(-49.7%) |
| Sep 2002 | - | $39.45 M(-5.1%) |
| Jun 2002 | - | $41.56 M(+36.8%) |
| Mar 2002 | - | $30.38 M(+80.9%) |
| Dec 2001 | $30.80 M(+478.9%) | - |
| Aug 2001 | - | $16.79 M(+778.3%) |
| May 2001 | - | $1.91 M(-79.9%) |
| Feb 2001 | - | $9.51 M(+78.7%) |
| Nov 2000 | $5.32 M(+106.2%) | $5.32 M(-48.5%) |
| Aug 2000 | - | $10.34 M(-2.0%) |
| May 2000 | - | $10.54 M(+264.3%) |
| Feb 2000 | - | $2.89 M(+12.2%) |
| Nov 1999 | $2.58 M | $2.58 M(+1828.7%) |
| Aug 1999 | - | $133.80 K(>+9900.0%) |
| May 1999 | - | $0.00(-100.0%) |
| Feb 1999 | - | $1.19 M |
FAQ
- What is Aurinia Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Aurinia Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Aurinia Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AUPH is $48.88 M
What is the all time high annual cash & cash equivalents for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual cash & cash equivalents is $306.02 M
What is Aurinia Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AUPH annual cash & cash equivalents has changed by -$45.30 M (-48.10%)
What is Aurinia Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AUPH is $37.14 M
What is the all time high quarterly cash and cash equivalents for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly cash and cash equivalents is $306.02 M
What is Aurinia Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AUPH quarterly cash and cash equivalents has changed by +$3.73 M (+11.18%)